Pharmacy-therapy commission
Objectives
Procedures
Composition
Organization
Confidentiality
Statment of clash
Indicators of quality
Guides and protocols
Bibliography
Agreements of the meeting
Commission reports
MEDICINE'S ALPHABETICAL LIST
+ DATE ORDER
Medicine
Report
Complementary Report
Àcid Zoledrònic
12-02-03
Amifostina
12-02-03
Anastrazol
20-10-04
Aprepitant
09-10-06
Azacitidina
17-07-08
Bevacizumab
22-09-05
09-01-09
31-01-08
Bicalutamida
09-05-03
Bortezomib
01-03-05
Buprenorfina
21-03-05
Busulfan
02-06-05
Caspofungina
09-05-03
17-03-04
Cetuximab
20-10-04
Cetuximab CCRm K-ras Wild
15-09-08
Cetuximab SCCHN 1ªL
08-03-07
Cetuximab SCCHN
29-01-07
Citarabina Liposomal
02-06-05
Dasatinib
29-06-07
Darbepoetina Alfa
12-02-03
17-03-04
Dexrazoxano
31-01-08
Docetaxel
07-06-05
05-07-07
Doxorubicina Liposomal
11-02-03
Doxorubicina Liposomal-PEG
12-01-06
31-01-08
Eculizumab
17-04-08
Epoetina Zeta
12-01-09
Erlotinib
07-12-06
Fentanil Oral Transmucosa
05-03-03
Filgrastim
09-01-09
Fotemustina
14-04-08
Gemcitabina
05-06-05
Ibandronat
13-07-06
Ibritumomab tiuxetà
05-07-07
Imatinib GIST
12-03-03
Imatinib Tractament LMC
05-03-03
Lenalidomida
31-01-08
17-07-08
Lapatinib
16-09-08
Nilotinib
17-06-08
Oxaliplatí
01-03-05
Oxicodona
01-03-05
Palifermina
05-07-07
Palonosetrón
09-10-07
Pegfilgrastim
14-10-03
Pemetrexed
31-05-05
Posaconazol
26-04-07
Rituximab
01-03-07
Sorafenib
02-05-07
22-10-07
Sunitinib
28-04-07
Talidomida
15-10-04
Temozolomida
07-07-05
Temsirolimus
17-06-08
Trabectidina
23-06-08
Trastuzumab
05-09-08
Valaciclovir
22-01-07
Valganciclovir
22-01-07
Vinorelbina
21-03-05
Vinorelbina oral
13-07-06
Voriconazol
17-03-04